The firm initiated coverage on an “oncology powerhouse” with a rich portfolio.
You are here: Home / This biotech stock is a cancer-fighting ‘powerhouse’ with nearly 50% upside, says Jefferies
Market News and Views
The firm initiated coverage on an “oncology powerhouse” with a rich portfolio.